From: End-stage renal disease preceded by rapid declines in kidney function: a case series
 | ESRD precipitated by ARF (N = 8) | ESRD not precipitated by ARF (N = 97) |
---|---|---|
Age at dialysis initiation (yrs) | 69.9 ± 19.2 | 66.9 ± 13.5 |
Male | 4 (50%) | 49 (50.5%) |
Race/Ethnicity, N (%) | Â | Â |
   White | 3 (37.5%) | 44 (45.3%) |
   Asian | 5 (62.5%) | 30 (30.9%) |
   Black | 0 | 21 (21.6%) |
   Hispanic | 0 | 2 (2.1%) |
Co-morbid conditions, N (%) | Â | Â |
   Hypertension | 6 (75%) | 85 (87.6%) |
   Diabetes mellitus | 4 (50%) | 41 (42.2%) |
   Congestive heart failure | 1 (12.5%) | 20 (20.6%) |
Initial renal replacement therapy modality, N (%) | Â | Â |
   Hemodialysis | 8 (100%) | 92 (94.8%) |
   Peritoneal dialysis (PD) | 0 | 5 (5.2%)* |
Access for dialysis, N (%) | Â | Â |
   Hemodialysis catheter | 8 (100%) | 69 (71.1%)¶ |
   Hemodialysis fistula | 0 | 22 (22.7%) |
   Hemodialysis graft | 0 | 1 (1.0%) |
   Peritoneal dialysis catheter | 0 | 5 (5.2%) |